Molecular Vision has announced the appointment of Peter Woodford as non-executive chairman.
The company said the appointment will strengthen the board as the company prepares to commercialise its detection technology, focusing on low-cost POC diagnostic tests in a miniaturised, disposable format.
Woodford has more than 35 years' experience in the diagnostics industry.
Most recently he spent 15 years with Roche Diagnostics/Boehringer Mannheim, where he was responsible for a GBP1.2bn budget for Roche Diabetes Care's global strategic and commercial activities.
